Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk of Cerebral Edema in Primary Mediastinal B Cell Lymphoma (PMBCL)
New safety information
Read the official notice →- Date
- 2025-12-10
- Country
- Canada
- Product
- Yescarta (axicabtagene ciloleucel) Suspension for Intravenous Infusion
- Category
- Drugs & medical
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other drugs & medical recalls in Canada
- 2025-12-17
CA
- 2025-12-16
CA
CA
- 2025-12-10
CA
Beckman Coulter AU Immunochemistry System- HDL/LDL Cholesterol Assay
Performance
Health CanadaOfficial notice →CA
- 2025-12-09
CA
Nitrous Oxide Chargers: Sold for Inhalation Without Market Authorization (DIN)
Product safety
Health CanadaOfficial notice →